GSK Drops as RSV Shot Suffers Fresh Blow With US Recommendation – BNN Bloomberg ...Middle East

canadian news today - News
GSK Drops as RSV Shot Suffers Fresh Blow With US Recommendation – BNN Bloomberg
(Bloomberg) — GSK Plc slumped after US health officials recommended restricting vaccination with its RSV shot to people who are older and more at risk in a move that could reduce the market for the UK drugmaker’s blockbuster vaccine.  The shares fell as much as 6.7% in early London trading, wiping out more than half of their gains for the year. The guidance marks the second blow to GSK this week after it lost out to rival Pfizer Inc. on a contract to supply millions of doses of the vaccine to its home country.  An advisory panel to the US Centers for Disease Control and Prevention only recommended vaccination in adults aged 60 to 74 if they were at risk of severe disease. RSV, or respirato

Hence then, the article about gsk drops as rsv shot suffers fresh blow with us recommendation bnn bloomberg was published today ( ) and is available on canadian news today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GSK Drops as RSV Shot Suffers Fresh Blow With US Recommendation – BNN Bloomberg )

Apple Storegoogle play

Last updated :

Also on site :